Clinical Trials Update: Oct. 15, 2008
Wednesday, October 15, 2008; 1:00 PM
Copyright © 2008 ScoutNews, LLC. All rights reserved. (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch: Memory Loss If you know someone aged 50 to 90 who has been diagnosed with probable Alzheimer's disease or has memory problems that may be a sign of Alzheimer's, is not taking any Alzheimer's medication, and has a regular caregiver who is willing to attend all trial visits, that person may qualify for this study. The research site is in Charlotte, N.C. More information Please see http://www.centerwatch.com/patient/studies/cat352.html. ----- Melanoma If you are 18 or older, have histologically confirmed metastatic (Stage IV) melanoma of cutaneous origin, an ECOG performance status of two or less, and a life expectancy of greater than 12 weeks, you may qualify for this study. advertisement
The research site is in Cincinnati, Ohio More information Please see http://www.centerwatch.com/patient/studies/cat791.html. ----- Epilepsy If you are aged 16 to 75, have well-characterized focal epilepsy or epileptic syndrome, and are on a stable dose of one or two antiepileptic drugs, you may qualify for this study. The research site is in Danville, Ind. More information Please see http://www.centerwatch.com/patient/studies/cat62.html. ----- Copyright 2008 CenterWatch. All rights reserved. Related Links
| ||
What's HOTGet our free newsletter
PR Newswire |
 |
The drkoop.com URL and web site are not associated with C. Everett Koop, M.D., former Surgeon General of the United States.
By using this service, you accept our Terms of Use. Please read them. The consumer health information on drkoop.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2004-2008. The HealthCentral Network, Inc. All rights reserved.